Viewing nowCombinationOlmesartan Medoxomil/Hydrochlorothiazide/Amlodipine Besilate 5/40/12.5mg Tablet
Olmesartan Medoxomil 40mg · Hydrochlorothiazide 12.5mg +1 more
Tablet · Prescription medication · Combination
DongKook Pharmaceutical Co., Ltd.

MFDS item code 202401352 · Approved 2024.05.31 · Insurance code 653405740
Treatment of essential hypertension not adequately controlled with combination therapy of S-amlodipine and olmesartan
The combination therapy of Amlodipine and Olmesartan Medoxomil is a helpful treatment for patients with essential hypertension who find it difficult to control blood pressure. This medication lowers blood pressure, reduces cardiovascular burden, and contributes to the prevention of stroke or heart disease. It is used to dilate blood vessels and maintain stable blood pressure, thereby reducing the risk of complications. This medication helps achieve effective blood pressure management.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) and olmesartan medoxomil) as monotherapy or combination therapy. However, if blood pressure is not controlled with combination therapy with S-amlodipine (amlodipine) and olmesartan medoxomil as described below, switching directly to this medicine may be considered. The maximum dose of this medicine is 5/40/25mg of S-amlodipine/olmesartan medoxomil/hydrochlorothiazide. Since the maximum blood pressure-lowering effect occurs within 2 weeks after administration, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses (in the order of S-amlodipine/olmesartan medoxomil/hydrochlorothiazide) are as follows. - 2.5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy with S-amlodipine/olmesartan medoxomil 2.5/20mg (amlodipine/olmesartan medoxomil 5/20mg). - 2.5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy with S-amlodipine/olmesartan medoxomil 2.5/40mg (amlodipine/olmesartan medoxomil 5/40mg), or with this medicine 2.5/20/12.5mg (amlodipine/olmesartan medoxomil/hydrochlorothiazide 5/20/12.5mg). - 2.5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 2.5/40/12.5mg (amlodipine/olmesartan medoxomil/hydrochlorothiazide 5/40/12.5mg). - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy with S-amlodipine/olmesartan medoxomil 5/40mg (amlodipine/olmesartan medoxomil 10/40mg), or with this medicine 2.5/40/12.5mg (amlodipine/olmesartan medoxomil/hydrochlorothiazide 5/40/12.5mg). - 5/40/25mg: For patients whose blood pressure is not adequately controlled with S-amlodipine/olmesartan medoxomil/hydrochlorothiazide 2.5/40/25mg (amlodipine/olmesartan medoxomil/hydrochlorothiazide 5/40/25mg), or with this medicine 5/40/12.5mg (amlodipine/olmesartan medoxomil/hydrochlorothiazide 10/40/12.5mg). ※ Refer to the following dose-escalation diagram. The content of each component is shown in the order of S-amlodipine/olmesartan medoxomil/hydrochlorothiazide (amlodipine/olmesartan medoxomil/hydrochlorothiazide). 2.5/20/0mg (5/20/0mg) → 2.5/20/12.5mg (5/20/12.5mg) ↓ 2.5/40/0mg (5/40/0mg) → 2.5/40/12.5mg (5/40/12.5mg) → 2.5/40/25mg (5/40/25mg) ↓ ↓ 5/40/0mg (10/40/0mg) → 5/40/12.5mg (10/40/12.5mg) → 5/40/25mg (10/40/25mg) ૦ Patients with renal impairment The maximum dose of this medicine for patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 2.5/20/12.5 milligrams once daily (amlodipine/olmesartan medoxomil/hydrochlorothiazide 5/20/12.5mg). Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). ૦ Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment. The maximum dose of this medicine for patients with moderate hepatic impairment is 2.5/20/12.5 milligrams once daily (amlodipine/olmesartan medoxomil/hydrochlorothiazide 5/20/12.5mg). Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. ૦ Older adults (65 years and older) In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In older adults, blood pressure should be monitored closely and more frequently. Experience with this medicine in older adults, particularly those aged 75 years and older, is very limited; therefore, patients should be monitored very carefully when this medicine is administered.
The safety and efficacy of this drug in pediatric patients under 18 years of age have not been established; therefore, its use is not recommended.
This medication may cause severe harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, thus it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies or hypersensitivity to this drug or its components, pregnant or breastfeeding women, those with severe hypotension, and patients with serious heart, kidney, or liver problems should not take this medication. Patients with low blood volume or electrolyte imbalance may experience hypotension when starting this drug, thus they should be monitored closely, and appropriate treatment should be provided if hypotension occurs. This medication can affect kidney function, so patients with weak kidney function should have regular blood tests, and those with severe kidney impairment should avoid taking this medication. Patients with impaired liver function should also use caution while taking this medication, and it is safer not to take it if there is severe liver disease. This medication has a blood pressure-lowering effect; therefore, caution is advised when performing activities that require concentration, such as driving or operating machinery, as dizziness or drowsiness may occur. While taking this medication, the skin may become sensitive to sunlight; therefore, it is recommended to use sunscreen and protect the skin when going outside. Elderly patients or those with a history of diabetes or gout should carefully monitor for electrolyte imbalances or changes in kidney function while taking this medication. Overdose of this medication may lead to severe hypotension, palpitations, and electrolyte imbalances, so it is essential to adhere to the prescribed dosage and regimen. If symptoms such as severe diarrhea, difficulty breathing, severe allergic reactions, visual disturbances, or severe swelling occur during treatment, consult a doctor immediately. This medication may interact with other antihypertensive drugs, diuretics, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs). Therefore, it is essential to inform healthcare providers of any other medications being taken. If breastfeeding, since this medication may be transmitted through breast milk to the baby, patients should consult with their doctor regarding whether to continue breastfeeding. The safety and efficacy of this medication have not been established in children under 18 years old, and therefore it is not recommended for use in this age group. This medication should be stored in a tightly sealed container, protected from moisture and heat, and kept out of reach of children. Transferring it to another container should be avoided.
Peripheral edema, headache, dizziness, upper respiratory tract infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, anorexia, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusion, depression, apathy, sensitivity to stimuli, anxiety, mood changes, sleep disturbances, dizziness, orthostatic dizziness, syncope, taste disturbance, hypertonia, sensory impairment, paresthesia, peripheral neuropathy, drowsiness, fainting, convulsions, loss of appetite, tremors, visual disturbances, reduced tear production, worsening of myopia, jaundice, vertigo, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, dyspnea, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, change in bowel habits, distension, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, vascular edema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like skin reaction, papulovesicular eruption, exfoliative dermatitis, hyperhidrosis, photosensitivity reaction, pruritus, purpura, Quincke's edema, rash, recurrence of skin lupus erythematosus, toxic skin necrosis, Stevens-Johnson syndrome, urticaria, muscle cramps, joint swelling, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, paresis, myalgia, bone pain, polyuria, acute renal failure, hematuria, urination disorders, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, ennui, edema, pain, facial edema, elevated serum creatinine levels, elevated blood urea levels, elevated serum uric acid levels, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated creatine phosphokinase in blood, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, intestinal vascular edema, altered consciousness, drug hypersensitivity, epigastric pain, decreased libido, periorbital edema, lethargy, eczema, limb pain, mild decrease in average hemoglobin and hematocrit levels, dizziness, benign prostatic hyperplasia, benign salivary gland neoplasm, cerebral infarction, renal failure, abdominal distension, facial flushing, nosebleeds, prostatic hyperplasia, prostatitis, dysphagia, papular rash, renal cell dysplasia, acute hearing loss, lymphadenitis, acute respiratory distress syndrome, choroidal effusion, hypotension, palpitations, bradycardia, electrolyte deficiencies due to excessive diuresis, dehydration, nausea, somnolence, non-cardiogenic pulmonary edema
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. Furthermore, it should be stored at room temperature, avoiding extremes of heat or cold, specifically between 1 degree and 30 degrees Celsius.
Round film-coated tablets in reddish color
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 40mg · Hydrochlorothiazide 12.5mg +1 more
Tablet · Prescription medication · Combination
DongKook Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Hydrochlorothiazide 12.5mg +1 more
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Hydrochlorothiazide 12.5mg +1 more
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.